Loading...
Home 2018-05-03T13:23:17+00:00

REVIVE

Welcome to REVIVE! Brought to you by GARDP’s Antimicrobial Memory Recovery & Exploratory Programme, REVIVE is a space for everybody with an interest in antimicrobial R&D.

Researchers and drug developers can connect with each other and with world-class experts from the golden age of antibiotic development.

Is your molecule novel? Is it “druggable”? Can it be optimized? Which bacteria needs targeting? What pitfalls should you watch out for? Find out this and more. Discuss with your peers from across the world, learn from our webinars, and ask our experts – here!

" I’m working for a CRO that is ending its microbiology drug development service. I’m looking into forming a spin out anti-infective CRO, but am keen on making sure that I get what potential clients want and need at start up, right from the business plan. I have a decent handle on what my current clients... "

3 days ago

" The commercial model for antibiotics is broken and that is hindering investment in antibiotic R&D. The situation was similar in rare diseases with low patient populations but his has been fixed in both USA and Europe by various actions such as the following: 1. Regulatory advantages – Orphan Drug Act and Orphan Designation 2. Market... "

3 months ago

" We would be very grateful if you would take a moment to fill in our survey here: https://www.surveymonkey.com/r/GARDP-REVIVE Thank you. "

3 months ago

ONE-TO-ONE DISCUSSION

Talk to an expert

Ask your question here and we will assign the best expert available to answer

Read more
Visit all Forums